OPTICLONE CD3/CD4 MONOCLONAL ANTIBODIES— 510(k) K950626

Substantially Equivalent

Immunotech Corp.

FDA 510(k) clearance K950626 for OPTICLONE CD3/CD4 MONOCLONAL ANTIBODIES, Substantially Equivalent on 1995-05-05. Applicant: Immunotech Corp..

Clearance details

Applicant: Immunotech Corp.
Product code: Code GKZ
Advisory panel: Hematology
Date received: 1995-02-10
Decision date: 1995-05-05
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Westbrook, ME, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code GKZ

product code GKZ

Malfunction: 1,205
Total: 1,205

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.